SEARCH

SEARCH BY CITATION

Reference

  • 1
    Decker JL: The management of systemic lupus erythematosus. Arthritis Rheum 25: 891894, 1982
  • 2
    Albert DA, Hadler NM, Rothfield NF: Survival in systemic lupus erythematosus. JAMA 239: 17411742, 1978
  • 3
    Dillon CF, Jones JV, Reichlin M: Antibody to Ro in a population of patients with systemic lupus erythematosus: distribution, clinical and serological associations. J Rheumatol 10: 380386, 1983
  • 4
    Urowitz MB, Gladman DD, Tozman ECS, Goldsmith CH: The Lupus Activity Criteria Count. J Rheumatol 11: 783787, 1984
  • 5
    Liang MH, Rogers M, Larson M, Eaton HM, Murawski BJ, Taylor JE, Swafford J, Schur PH: The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 27: 1319, 1984
  • 6
    Valentijn RM, van Overhagen H, Hazevoet HM, Hermans J, Cats A, Daha MR, van Es LA: The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 28: 904913, 1985
  • 7
    Bacon PA, Coppock JS, Isenberg DA, Maddison PJ, Snaith ML, Symmons DPM, Zoma AA: A comparison of disease activity scores in systemic lupus erythematosus (abstract). Br J Rheumatol 15: 16, 1986
  • 8
    Morimoto C, Sano H, Abe T, Homma M, Steinberg AD: Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA/anti-DNA antibody immune complexes. J Immunol 129: 19601965, 1982
  • 9
    Pearson L, Lightfoot RW Jr: Correlation of DNA-anti-DNA association rates with clinical activity in systemic lupus erythematosus. J Immunol 126: 1619, 1981
  • 10
    Smolen JS, Chused TM, Leiserson WM, Reeves JP, Alling D, Steinberg AD: Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Am J Med 72: 783790, 1982
  • 11
    Weitzman RJ, Walker SE: Relation of titered peripheral pattern antinuclear antibodies to anti-DNA and disease activity in systemic lupus erythematosus. Ann Rheum Dis 36: 4449, 1977
  • 12
    Hurd ER, Jasin HE, Gilliam JN: Correlation of disease activity and C1q-binding immune complexes with the neutrophil inclusions which form in the presence of systemic lupus erythematosus sera. Clin Exp Immunol 40: 283291, 1980
  • 13
    Cairns SA, London A, Mallick NP: The value of three immune complex assays in the management of systemic lupus erythematosus: an assessment of immune complex levels, size and immunochemical properties in relation to disease activity and manifestations. Clin Exp Immunol 40: 273282, 1980
  • 14
    Sagawa A, Abdou NI: Supressor-cell antibody in systemic lupus erythematosus: possible mechanism for suppressor cell dysfunction. J Clin Invest 63: 536539, 1979
  • 15
    Tozman ECS, Urowitz MB, Gladman DD: Systemic lupus erythematosus and pregnancy. J Rheumatol 7: 624632, 1980
  • 16
    Abrass CK, Nies KM, Louie JS, Border WA, Glassock RJ: Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 23: 273282, 1980
  • 17
    Morrow WJW, Isenberg DA, Todd-Pokropek AT, Parry HF, Snaith ML: Useful laboratory measurements in the management of systemic lupus erythematosus. Q J Med 202: 125138, 1982
  • 18
    Ropes MW: Systemic Lupus Erythematosus. Boston, Harvard University Press, 1976
  • 19
    Hardin JA, Cronlund M, Haber E, Bloch KJ: Activation of blood clotting in patients with systemic lupus erythematosus: relationship to disease activity. Am J Med 65: 430436, 1978
  • 20
    Rothfield NF, Stollar BD: The relationship of immunoglobulin class, pattern of anti-nuclear antibody and complement fixing antibodies to DNA in sera from patients with SLE. J Clin Invest 46: 17851794, 1967
  • 21
    Lockshin MD, Reinitz E, Druzin ML, Murrman M, Estes D: Lupus pregnancy: case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 77: 893898, 1984
  • 22
    Klippel JH, Karsh J, Stahl NI, Decker JL, Steinberg AD, Schiffman G: A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum 22: 13211325, 1979
  • 23
    Winfield JB: Assessment of disease activity in systemic lupus erythematosus (abstract). Arthritis Rheum 15: 462, 1972
  • 24
    Inman RD, Fong JKK, Pussell BA, Ryan PJ, Hughes GRV: The C1q binding assay in systemic lupus erythematosus: discordance with disease activity. Arthritis Rheum 23: 12821286, 1980
  • 25
    Rivero SJ, Llorente L, Díaz-Jouanen E, Alarcón-Segovia D: T-lymphocyte subpopulation in untreated SLE: variations with disease activity. Arthritis Rheum 20: 11691173, 1977
  • 26
    Committee on Prognosis Studies in SLE: Prognosis studies in SLE: an activity index (abstract). Arthritis Rheum 29 (suppl 4): S93, 1986
  • 27
    Buyon JP, Cronstein BN, Morris M, Tanner M, Weissmann G: Serum complement values (C3 and C4) to differentiate between systemic lupus activity and preeclampsia. Am J Med 81: 194200, 1986
  • 28
    Rebhun J, Quismorio F Jr, Dubois E, Heiner DC: Systemic lupus erythematosus activity and IgE. Ann Allergy 50: 3436, 1983
  • 29
    Klippel JH, Grimley PM, Decker JL, Michelitch HJ: Lymphocyte tubuloreticular structures in lupus erythematosus: correlation with disease activity. Ann Intern Med 81: 355357, 1974
  • 30
    Ytterberg SR, Schnitzer TJ: Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon. Ann Rheum Dis 43: 457461, 1984
  • 31
    McCoubrey-Hoyer A, Okarma TB, Holman HR: Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus. Am J Med 77: 2334, 1984
  • 32
    Edmonds JP, Bruneau C, Hughes GR: Assessment of activity in systemic lupus erythematosus: a clinical and serological study. Ann Rheum Dis 34: 543544, 1975
  • 33
    Bruneau C, Edmonds JP, Hughes GR: Proceedings: circulating complexes and disease activity in systemic lupus erythematosus. Ann Rheum Dis 34: 469, 1975
  • 34
    Mackworth-Young CG, Chan JK, Bunn CC, Hughes GR, Gharavi AE: Complement fixation by anti-dsDNA antibodies in systemic lupus erythematosus: measurement by radioimmunoassay and relationship with disease activity. Ann Rheum Dis 45: 314318, 1986
  • 35
    Halberg P, Ullman S, Jorgensen F: The lupus band test as a measure of disease activity in systemic lupus erythematosus. Arch Dermatol 118: 572576, 1982
  • 36
    Bakke AC, Kirkland PA, Kitridou RC, Quismorio FP Jr, Rea T, Ehresmann GR, Horwitz DA: T lymphocyte subsets in systemic lupus erythematosus: correlation with corticosteroid therapy and disease activity. Arthritis Rheum 26: 745750, 1983
  • 37
    Kassan SS, Kagen LJ: Central nervous system lupus erythematosus: measurement of cerebrospinal fluid cyclic GMP and other clinical markers of disease activity. Arthritis Rheum 22: 449457, 1979
  • 38
    Hamilton ME, Winfield JB: Tγ cells in systemic lupus erythematosus: variation with disease activity. Arthritis Rheum 22: 16, 1979
  • 39
    Rosenthal CJ, Franklin EC: Depression of cellular-mediated immunity in systemic lupus erythematosus: relation to disease activity. Arthritis Rheum 18: 207217, 1975
  • 40
    Klippel JH, Grimley PM, Decker JL, Michelitch HJ: Lymphocyte tubuloreticular structures—disease activity correlation and sequential studies in systemic lupus erythematosus (abstract). Arthritis Rheum 17: 322, 1974
  • 41
    Clark WF, Linton AL, Cordy PE, Keown PE, Lohmann RC, Lindsay RM: Immunologic findings, thrombocytopenia and disease activity in lupus nephritis. Can Med Assoc J 118: 13911395, 1978
  • 42
    Smith JB, deHoratius RJ: Deficient autologus mixed lymphocyte reactions correlate with disease activity in systemic lupus erythematosus and rheumatoid arthritis. Clin Exp Immunol 48: 155162, 1982
  • 43
    Kallenberg CG, Schweitzer C, deJong PE, Donker AJ, van der Hem GK: Decreased filtration fraction during active proliferative lupus nephritis: relation to disease activity and reversibility of renal function. Clin Nephrol 22: 223229, 1984
  • 44
    Sturfelt G, Sjholm AG, Svensson B: Complement components, C1 activation and disease activity in systemic lupus erythematosus. Int Arch Allergy Appl Immunol 70: 1218, 1983
  • 45
    Sakane T, Takada S, Suzuki N, Tsuchida T, Murakawa Y, Ueda Y: Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells. J Immunol 137: 38093813, 1986
  • 46
    Singsen BH, Bernstein BH, King KK, Hanson V: Systemic lupus erythematosus in childhood correlations between changes in disease activity and serum coment levels. J Pediatr 89: 358369, 1976
  • 47
    Via CS, Allen RC, Welton RC: Direct stimulati neutrophil oxygenation activity by serum from pat with systemic lupus erythematosus: a relationship disease activity. J Rheumatol 11: 745753, 1984
  • 48
    Scheinberg MA, Israel Filho G, Mendes NF, Vertz L: Suppression of C3 rosette formation by serum patients with systemic lupus erythematosus: a coro of disease activity. J Rheumatol 5: 1925, 1978
  • 49
    Utsinger PD: Relationship of lymphocytic antibod lymphopenia and parameters of disease activity in temic lupus erythematosus. J Rheumatol 3: 175185,
  • 50
    Kirsner AB, Diller JG, Sheon RP: Systemic lupus thematosus with cutaneous ulceration: correlation immunologic factors with therapy and clinical acti JAMA 217: 821823, 1971
  • 51
    Schur PH, Sandson J: Immunologic factors and clin activity in systemic lupus erythematosus. N Engl J 278: 533538, 1968
  • 52
    Okudaira K, Tanimoto K, Aikawa T, Horiuchi Y, Suka S: Heterogeneity of antilymphocyte antibod SLE and its correlation with disease activity. Scan Rheumatol 12: 2128, 1978
  • 53
    Parris TM, Kimberly RP, Inman RD, McDougal Gibofsky A, Christian CL: Defective Fc receptor-mated function of the mononuclear phagocyte syste lupus nephritis. Ann Intern Med 97: 526532, 1982
  • 54
    Michalecicz R, Many A, Ramot B: Peripheral b lymphocytes in systemic lupus erythematosus: rela to activity. Acta Haematol (Basel) 57: 199205, 1977
  • 55
    Bell DA: Cell-mediated immunity in systemic lu erythematosus: observations on in vitro cell-media immune responses in relationship to number of potially reactive T cells, disease activity, and treatm Clin Immunol Immunopathol 9: 301317, 1978
  • 56
    Harkiss GD, Hazleman BL, Brown DL: A longitud study of circulating immune complexes, DNA antibies and complement in patients with systemic lu erythematosus: an analysis of their relationship to ease activity. J Clin Lab Immunol 2: 275283, 1979
  • 57
    Chitrabamrung S, Rubin RL, Tan EM: Serum deox bonuclease I and clinical activity in systemic lu erythematosus. Rheumatol Int 1: 5560, 1981
  • 58
    Lahita RG, Bradlow HL, Ginzler E, Pang S, New Low plasma androgens in women with systemic lu erythematosus. Arthritis Rheum 30: 241248, 1987
  • 59
    Barada FA Jr, Andrews BS, Davis JS IV, Taylor RP Antibodies to Sm in patients with systemic lupus thematosus: correlation of Sm antibody titers with ease activity and other laboratory parameters. Arth Rheum 24: 12361244, 1981
  • 60
    Rothfield NF, Pace N: Relation of positive LE preparations to activity of lupus erythematosus corticosteroid therapy. N Engl J Med 266: 535538, 1962
  • 61
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane Rothfield NF, Schaller JG, Talal N, Winchester RJ: 1982 revised criteria for the classification of syste lupus erythematosus. Arthritis Rheum 25: 12711277, 1982
  • 62
    Nunnally J: Tests and Measurements: Assessment Prediction. New York, McGraw-Hill, 1959
  • 63
    Feinstein AR: Clinimetrics. New Haven, CT, Yale University Press, 1987
  • 64
    Feinstein AR: A bibliography of publications on observer variability. J Chronic Dis 38: 619632, 1985
  • 65
    Liang MH, Larson MG, Cullen KE, Schwartz JA: Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 28: 542547, 1985
  • 66
    Woodbury MA, Clive JM: Continuous and discrete models of disease. Mathematical Modeling 7: 118, 1986
  • 67
    Liang MH, Stern S, Esdaile JM: Towards an operational definition of SLE activity for clinical research. Clin Rheum Dis (in press)
  • 68
    Anderson G, Bombardier C: Estimating disease activity in rheumatoid arthritis. Med Decis Making 4: 469474, 1984
  • 69
    Blois MS: Clinical judgment and computers. N Engl J Med 303: 192197, 1980
  • 70
    Susser M: Judgment and causal inference: criteria in epidemiologic studies. Am J Epidemiol 105: 115, 1977
  • 71
    ARA Glossary Committee: Dictionary of the Rheumatic Diseases. Vol. I. New York, Contact Associates, 1982
  • 72
    ARA Glossary Committee: Dictionary of the Rheumatic Diseases. Vol. II. New York, Contact Associates, 1985
  • 73
    Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. JAMA 140: 659662, 1949